Decoupling cell growth and product formation in Chinese hamster ovary cells through metabolic control

被引:51
作者
Altamirano, C [1 ]
Cairó, JJ [1 ]
Gòdia, F [1 ]
机构
[1] Univ Autonoma Barcelona, Escola Tecn Super Engn, Dept Engn Quim, E-08193 Barcelona, Spain
关键词
Chinese hamster ovary (CHO) cells; arrested cells; glutamate and glucose replacement; biphasic culture;
D O I
10.1002/bit.10096
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of a strategy for the culture of Chinese hamster ovary (CHO) cells producing tissue plasminogen activator (t-PA) is investigated. This strategy is based on the replacement of the main carbon source, glucose, by another compound that is slowly metabolizable, particularly galactose. The introduction of this change allows for acute change in cell behavior at various levels. Cell growth is stopped after this nutrient shift, and the cells can be kept in long-duration culture at a low growth rate and high viability as compared with a culture strategy based solely on glucose utilization. Moreover, the capability of cells to produce recombinant proteins (t-PA in this work) can be maintained over the entire period of galactose feeding. From the metabolic point of view, use of a slowly metabolizable carbon source (galactose) introduces important changes in the production of lactate, ammonia, and some amino acids. The use of this metabolic shift enables the generation of biphasic processes, with a first phase with cell growth on glucose and a second stationary phase on galactose, which is particularly suited to perfusion systems. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:351 / 360
页数:10
相关论文
共 54 条
[1]   SPECIFIC MONOCLONAL-ANTIBODY PRODUCTIVITY AND THE CELL CYCLE-COMPARISONS OF BATCH, CONTINUOUS AND PERFUSION CULTURES [J].
ALRUBEAI, M ;
EMERY, AN ;
CHALDER, S ;
JAN, DC .
CYTOTECHNOLOGY, 1992, 9 (1-3) :85-97
[2]   Improvement of CHO cell culture medium formulation:: Simultaneous substitution of glucose and glutamine [J].
Altamirano, C ;
Paredes, C ;
Cairó, JJ ;
Gòdia, F .
BIOTECHNOLOGY PROGRESS, 2000, 16 (01) :69-75
[3]   MONOCLONAL-ANTIBODY PROCESS-DEVELOPMENT USING MEDIUM CONCENTRATES [J].
BIBILA, TA ;
RANUCCI, CS ;
GLAZOMITSKY, K ;
BUCKLAND, BC ;
AUNINS, JG .
BIOTECHNOLOGY PROGRESS, 1994, 10 (01) :87-96
[4]   EFFECT OF TEMPERATURE ON HYBRIDOMA CELL-CYCLE AND MAB PRODUCTION [J].
BLOEMKOLK, JW ;
GRAY, MR ;
MERCHANT, F ;
MOSMANN, TR .
BIOTECHNOLOGY AND BIOENGINEERING, 1992, 40 (03) :427-431
[5]  
Bonarius HPJ, 1999, ANIMAL CELL TECHNOLOGY: PRODUCTS FROM CELLS, CELLS AS PRODUCTS, P39
[6]   DETERMINATION OF AMMONIUM AND L-GLUTAMINE IN HYBRIDOMA CELL-CULTURES BY SEQUENTIAL FLOW-INJECTION ANALYSIS [J].
CAMPMAJO, C ;
CAIRO, JJ ;
SANFELIU, A ;
MARTINEZ, E ;
ALEGRET, S ;
GODIA, F .
CYTOTECHNOLOGY, 1994, 14 (03) :177-182
[7]  
Carvalhal AV, 1999, ANIMAL CELL TECHNOLOGY: PRODUCTS FROM CELLS, CELLS AS PRODUCTS, P175
[8]   GLUCOSE AND GLUTAMINE-METABOLISM OF A MURINE B-LYMPHOCYTE HYBRIDOMA GROWN IN BATCH CULTURE [J].
FITZPATRICK, L ;
JENKINS, HA ;
BUTLER, M .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1993, 43 (02) :93-116
[9]  
Fussenegger M, 1997, BIOTECHNOL BIOENG, V55, P927, DOI 10.1002/(SICI)1097-0290(19970920)55:6<927::AID-BIT10>3.0.CO
[10]  
2-4